He is a core member of Chinese Society of Clinical Oncology（CSCO）and biomarker, and a Member of the International Association Study of Lung Cancer(IASLC). He graduated from Sun Yat-sen University of Medical Sciences. His main research interests are the clinical and translational study of multimodality treatment of non-small cell lung cancer: 1. the multidisciplinary synthetic therapy in stage IIIa-N2 lung cancer; 2. Tumor heterogeneity of lung cancer and indolent lung cancer; 3. Clinical trial of peri-operative therapy of resectable lung cancer. He is the associate editor of J Thorac Oncol.